Cormica has been named the UK's top microbiological testing service for 2025.
Cormica, whose Wickham Micro laboratory is based in Gosport, received the award from Life Sciences Review, recognising its technical capabilities and contribution to patient safety.
The company, centred at its UK laboratory Wickham Micro, which has more than 60 years of prestige, was recognised following a process of industry nominations and independent research.
Mark Hammond, chief executive of Cormica, said: "This recognition is a testament to the dedication, expertise, and collaboration of our microbiology team.
READ MORE: Southampton occupational health firm celebrates 30th anniversary
"Wickham Micro has a long-standing reputation for excellence and innovation, and this award reinforces our continued focus on helping clients navigate complex testing and regulatory demands.
"I want to thank our clients for their trust and congratulate every member of the team on this achievement."
Cormica’s services include sterility and endotoxin testing, microbial identification, environmental monitoring, and custom method development to support healthcare manufacturers worldwide.
Dr Rob Turner, general manager at Wickham Micro, said: "First and foremost, the two biggest things we value are quality and patient safety. That comes above all else we do.
"Our customers face increased regulation and rising cost pressures.
"They want a partner they trust, who understands the regulations, follows them precisely, and delivers results in a cost-effective and timely way.
"We have the in-house expertise to take on unique or unconventional projects, not just standard regulatory testing.
"We have a lot of technical expertise and knowledge transfer to apply from one client and study to another. That is what sets us apart."
READ MORE: Eco warrior celebrated as he receives national citizen award
Cormica operates a global network of accredited laboratories across the UK, EU, and USA, offering microbiology, analytical chemistry, physical and functional testing, and consultancy services from early R and D to post-market surveillance.
The company supports pharmaceutical and medical device manufacturers with compliant testing that accelerates regulatory approval and commercial release.
Share